ストックスクリーナーアプリを入手
31.98
0.19%
0.115
前日終値:
$32.10
開ける：
$32.15
24時間の取引高:
394.04K
Relative Volume:
1.01
時価総額：
$1.61B
収益：
$345.60M
当期純損益:
$-79.01M
株価収益率:
-19.93
EPS:
-1.6045
ネットキャッシュフロー:
$-18.62M
1週間 パフォーマンス:
-1.86%
1か月 パフォーマンス:
-0.77%
6か月 パフォーマンス:
+7.02%
1年 パフォーマンス:
-12.85%
1日の値動き範囲:
$31.24
$33.12
1週間の範囲:
$30.99
$33.49
52週間の値動き範囲:
$23.15
$39.33
Immunocore Holdings Plc Adr Stock (IMCR) Company Profile
名前
Immunocore Holdings Plc Adr
セクター
電話
01235 5430281
住所
90 PARK DRIVE, OXFORDSHIRE
IMCR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMCR
Immunocore Holdings Plc Adr
|
32.00 | 1.63B | 345.60M | -79.01M | -18.62M | -1.6045 |
|
VRTX
Vertex Pharmaceuticals Inc
|
377.80 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.49 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.89 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
667.94 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.19 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-27 | 開始されました | Deutsche Bank | Buy |
| 2024-12-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-11-11 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-10-24 | 開始されました | UBS | Sell |
| 2024-10-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-04-29 | 開始されました | Leerink Partners | Outperform |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2023-09-13 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-13 | 開始されました | Needham | Buy |
| 2023-08-16 | 開始されました | CapitalOne | Overweight |
| 2023-07-17 | 開始されました | Canaccord Genuity | Hold |
| 2023-03-31 | 開始されました | Mizuho | Buy |
| 2023-03-30 | 開始されました | Guggenheim | Buy |
| 2023-03-24 | 開始されました | Bryan Garnier | Buy |
| 2022-12-16 | アップグレード | Goldman | Neutral → Buy |
| 2022-11-30 | 開始されました | Barclays | Overweight |
| 2022-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-08-08 | 開始されました | Cowen | Outperform |
| 2022-08-02 | 開始されました | BTIG Research | Buy |
| 2022-02-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-20 | 開始されました | Oppenheimer | Outperform |
| 2021-03-02 | 開始されました | Goldman | Neutral |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
| 2021-03-02 | 開始されました | Jefferies | Buy |
すべてを表示
Immunocore Holdings Plc Adr (IMCR) 最新ニュース
Immunocore (IMCR) Q2 Revenue Jumps 30% - The Motley Fool
Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Immunocore Holdings earnings missed by $0.02, revenue topped estimates - Investing.com
Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut - Yahoo Finance
TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line - sharewise.com
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Barchart.com
Immunocore to Report Q2 2025 Financial Results on August 7, 2025 - AInvest
Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $58.89 - Defense World
Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - Yahoo Finance
The IMCR Stock Puzzle: Unraveling Immunocore Holdings plc ADR’s Fluctuating Performance - investchronicle.com
Can Mizuho Financial Group, Inc. ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Principal Financial Group Inc. Reduces Stock Holdings in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) - Defense World
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - sharewise.com
COGT Stock Soars on Phase III Systemic Mastocytosis Study Success - sharewise.com
Apellis Stock Rises On $300M Royalty Deal With Sobi For Aspaveli - Barchart.com
Oppenheimer Asset Management Inc. Makes New Investment in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) - Defense World
Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - MSN
Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges By Investing.com - Investing.com South Africa
Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges - Investing.com India
Brokers Set Expectations for Immunocore FY2026 Earnings - Defense World
GAMMA Investing LLC Boosts Stock Position in Immunocore Holdings plc (NASDAQ:IMCR) - Defense World
Immunocore at Jefferies Global Healthcare Conference: Strong Growth and Promising Trials - Investing.com India
H.C. Wainwright reiterates buy rating on Immunocore stock amid ASCO update - Investing.com
Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet - sharewise
Deutsche Bank sets $65 target on Immunocore stock, rates Buy - Investing.com
Deutsche Bank sets $65 target on Immunocore stock, rates Buy By Investing.com - Investing.com India
Immunocore’s SWOT analysis: biotech firm’s stock faces challenges amid growth - Investing.com India
Is it a Good Idea to Invest in Immunocore Stock Right Now? - MSN
Balance Sheet Dive: Hippo Holdings Inc (HIPO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX
New Strong Buy Stocks for May 8th - The Globe and Mail
Immunocore stock rises as Q1 results top estimates By Investing.com - Investing.com South Africa
Immunocore stock rises as Q1 results top estimates - Investing.com
Immunocore Holdings earnings beat by $0.49, revenue topped estimates - Investing.com
Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
ESPR's Q1 Earnings Miss Estimates, Revenues Beat, Stock Down - Barchart.com
AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - The Globe and Mail
Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates - Barchart.com
Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com
Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet - Yahoo Finance
Mizuho cuts Immunocore stock price target to $33 from $38 - Investing.com
Immunocore stock hits 52-week low at $27.19 amid market challenges By Investing.com - Investing.com South Africa
Immunocore stock hits 52-week low at $27.19 amid market challenges - Investing.com
Do investors need to be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News
Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last? - MSN
Immunocore holdings sees $23.99 million in stock purchases by Baker Bros - Investing.com South Africa
Immunocore Holdings Plc Adr (IMCR) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.27%
大文字化:
|
ボリューム (24 時間):